+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Gastric Cancer - Pipeline Review, H2 2019

  • ID: 4894224
  • Drug Pipelines
  • December 2019
  • Region: Global
  • 2044 pages
  • Global Markets Direct
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 3

FEATURED COMPANIES

  • 3SBio Inc
  • Aurora BioPharma Inc
  • Cytodyn Inc
  • Good T Cells Inc
  • Kymab Ltd
  • Oncolys BioPharma Inc
  • MORE
Gastric Cancer - Pipeline Review, H2 2019

Summary

This latest Pharmaceutical and Healthcare disease pipeline guide Gastric Cancer - Pipeline Review, H2 2019, provides an overview of the Gastric Cancer (Oncology) pipeline landscape.

Gastric cancer, also called stomach cancer, is a malignant tumor arising from the lining of the stomach. Signs and symptoms of gastric cancer include fatigue, stomach pain, vomiting, weight loss that is unintentional, feeling bloated after eating, heartburn and indigestion. Risk factors include smoking, pernicious anemia, stomach polyps, infection with helicobacter pylori and family history of stomach cancer. Treatment includes surgery, chemotherapy and radiation therapy.

Report Highlights

This Pharmaceutical and Healthcare latest pipeline guide Gastric Cancer - Pipeline Review, H2 2019, provides comprehensive information on the therapeutics under development for Gastric Cancer (Oncology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Gastric Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Gastric Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Filing rejected/Withdrawn, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 3, 2, 14, 107, 158, 9, 143, 20 and 7 respectively. Similarly, the Universities portfolio in Phase II, Phase I, IND/CTA Filed, Preclinical and Discovery stages comprises 11, 8, 1, 9 and 4 molecules, respectively.

Gastric Cancer (Oncology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from the publisher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope
  • The pipeline guide provides a snapshot of the global therapeutic landscape of Gastric Cancer (Oncology).
  • The pipeline guide reviews pipeline therapeutics for Gastric Cancer (Oncology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
  • The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
  • The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
  • The pipeline guide reviews key companies involved in Gastric Cancer (Oncology) therapeutics and enlists all their major and minor projects.
  • The pipeline guide evaluates Gastric Cancer (Oncology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
  • The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
  • The pipeline guide reviews latest news related to pipeline therapeutics for Gastric Cancer (Oncology)
Reasons to buy
  • Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
  • Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Find and recognize significant and varied types of therapeutics under development for Gastric Cancer (Oncology).
  • Classify potential new clients or partners in the target demographic.
  • Develop tactical initiatives by understanding the focus areas of leading companies.
  • Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.
  • Formulate corrective measures for pipeline projects by understanding Gastric Cancer (Oncology) pipeline depth and focus of Indication therapeutics.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
  • Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • 3SBio Inc
  • Aurora BioPharma Inc
  • Cytodyn Inc
  • Good T Cells Inc
  • Kymab Ltd
  • Oncolys BioPharma Inc
  • MORE
Introduction
Gastric Cancer - Overview
Gastric Cancer - Therapeutics Development
Gastric Cancer - Therapeutics Assessment
Gastric Cancer - Companies Involved in Therapeutics Development
Gastric Cancer - Drug Profiles
Gastric Cancer - Dormant Projects
Gastric Cancer - Discontinued Products
Gastric Cancer - Product Development Milestones
Appendix

List of Tables
Number of Products under Development for Gastric Cancer, H2 2019
Number of Products under Development by Companies, H2 2019
Number of Products under Development by Universities/Institutes, H2 2019
Number of Products under Development by Universities/Institutes, H2 2019 (Contd..1), H2 2019
Products under Development by Companies, H2 2019
Products under Development by Universities/Institutes, H2 2019
Products under Development by Universities/Institutes, H2 2019 (Contd..1), H2 2019
Number of Products by Stage and Target, H2 2019
Number of Products by Stage and Mechanism of Action, H2 2019
Number of Products by Stage and Route of Administration, H2 2019
Number of Products by Stage and Molecule Type, H2 2019
Gastric Cancer - Pipeline by 3SBio Inc, H2 2019
Gastric Cancer - Pipeline by AbbVie Inc, H2 2019
Gastric Cancer - Pipeline by AbClon Inc, H2 2019
Gastric Cancer - Pipeline by AbGenomics International Inc, H2 2019
Gastric Cancer - Pipeline by Abion Inc, H2 2019
Gastric Cancer - Pipeline by ABL Bio Inc, H2 2019
Gastric Cancer - Pipeline by Abpro Corp, H2 2019
Gastric Cancer - Pipeline by AD Pharmaceuticals Co Ltd, H2 2019
Gastric Cancer - Pipeline by Adaptimmune Therapeutics Plc, H2 2019
Gastric Cancer - Pipeline by ADC Therapeutics SA, H2 2019
Gastric Cancer - Pipeline by Advenchen Laboratories LLC, H2 2019
Gastric Cancer - Pipeline by Akeso Biopharma Inc, H2 2019
Gastric Cancer - Pipeline by Alkermes Plc, H2 2019
Gastric Cancer - Pipeline by Allist Shanghai Pharmaceutical Technology Co Ltd, H2 2019
Gastric Cancer - Pipeline by Alteogen Inc, H2 2019
Gastric Cancer - Pipeline by Altor Bioscience LLC, H2 2019
Gastric Cancer - Pipeline by Ambrx Inc, H2 2019
Gastric Cancer - Pipeline by amcure GmbH, H2 2019
Gastric Cancer - Pipeline by Amgen Inc, H2 2019
Gastric Cancer - Pipeline by Andes Biotechnologies, H2 2019
Gastric Cancer - Pipeline by Anew Oncology Inc, H2 2019
Gastric Cancer - Pipeline by Antikor Biopharma Ltd, H2 2019
Gastric Cancer - Pipeline by Apollomics Inc, H2 2019
Gastric Cancer - Pipeline by Apotex Inc, H2 2019
Gastric Cancer - Pipeline by Arbele Ltd, H2 2019
Gastric Cancer - Pipeline by Argonaut Therapeutics Ltd, H2 2019
Gastric Cancer - Pipeline by Arromax Pharmatech Co Ltd, H2 2019
Gastric Cancer - Pipeline by Asana BioSciences LLC, H2 2019
Gastric Cancer - Pipeline by Ascelia Pharma AB, H2 2019
Gastric Cancer - Pipeline by Ascenta Therapeutics Inc, H2 2019
Gastric Cancer - Pipeline by AskAt Inc, H2 2019
Gastric Cancer - Pipeline by Aslan Pharmaceuticals Ltd, H2 2019
Gastric Cancer - Pipeline by Astellas Pharma Inc, H2 2019
Gastric Cancer - Pipeline by AstraZeneca Plc, H2 2019
Gastric Cancer - Pipeline by Atara Biotherapeutics Inc, H2 2019
Gastric Cancer - Pipeline by Aurigene Discovery Technologies Ltd, H2 2019
Gastric Cancer - Pipeline by Aurora BioPharma Inc, H2 2019
Gastric Cancer - Pipeline by Basilea Pharmaceutica Ltd, H2 2019
Gastric Cancer - Pipeline by Bayer AG, H2 2019
Gastric Cancer - Pipeline by BeiGene Ltd, H2 2019
Gastric Cancer - Pipeline by Beijing BGI-GBI Biotech Co Ltd, H2 2019
Gastric Cancer - Pipeline by Beijing Hanmi Pharmaceutical Co Ltd, H2 2019
Gastric Cancer - Pipeline by Beijing Mabworks Biotech Co Ltd, H2 2019
Gastric Cancer - Pipeline by Beijing Syngentech Co Ltd, H2 2019
Gastric Cancer - Pipeline by Bellicum Pharmaceuticals Inc, H2 2019
Gastric Cancer - Pipeline by Benhealth Biopharmaceutical (Shenzhen) Co Ltd, H2 2019
Gastric Cancer - Pipeline by Betta Pharmaceuticals Co Ltd, H2 2019
Gastric Cancer - Pipeline by Bio-Thera Solutions Ltd, H2 2019
Gastric Cancer - Pipeline by BioIntegrator Ltd, H2 2019
Gastric Cancer - Pipeline by BioLineRx Ltd, H2 2019
Gastric Cancer - Pipeline by BioMed Valley Discoveries Inc, H2 2019
Gastric Cancer - Pipeline by Biosion Inc, H2 2019
Gastric Cancer - Pipeline by Biotecnol Ltd, H2 2019
Gastric Cancer - Pipeline by Boehringer Ingelheim International GmbH, H2 2019
Gastric Cancer - Pipeline by Boston Biomedical Inc, H2 2019
Gastric Cancer - Pipeline by Bristol-Myers Squibb Co, H2 2019
Gastric Cancer - Pipeline by CalyGene Biotechnology Inc, H2 2019
Gastric Cancer - Pipeline by Camel-IDS NV, H2 2019
Gastric Cancer - Pipeline by Cancer Prevention Pharmaceuticals Inc, H2 2019
Gastric Cancer - Pipeline by CARsgen Therapeutics Ltd, H2 2019
Gastric Cancer - Pipeline by CAS-Lamvac Biotech Co Ltd, H2 2019
Gastric Cancer - Pipeline by Catalent Inc, H2 2019
Gastric Cancer - Pipeline by Celgene Corp, H2 2019
Gastric Cancer - Pipeline by Celldex Therapeutics Inc, H2 2019
Gastric Cancer - Pipeline by Cellestia Biotech AG, H2 2019
Gastric Cancer - Pipeline by Cellid Co Ltd, H2 2019
Gastric Cancer - Pipeline by Cellivery Therapeutics Inc, H2 2019
Gastric Cancer - Pipeline by Cello Therapeutics Inc, H2 2019
Gastric Cancer - Pipeline by Cellular Biomedicine Group Inc, H2 2019
Gastric Cancer - Pipeline by Celon Pharma SA, H2 2019
Gastric Cancer - Pipeline by Chia Tai Tianqing Pharmaceutical Group Co Ltd., H2 2019
Gastric Cancer - Pipeline by Chipscreen Biosciences Ltd, H2 2019
Gastric Cancer - Pipeline by Chugai Pharmaceutical Co Ltd, H2 2019
Gastric Cancer - Pipeline by CMG Pharmaceutical Co Ltd, H2 2019
Gastric Cancer - Pipeline by Coherent Biopharma, H2 2019
Gastric Cancer - Pipeline by Convalife, H2 2019
Gastric Cancer - Pipeline by Cristal Therapeutics BV, H2 2019
Gastric Cancer - Pipeline by CSPC Pharmaceutical Group Ltd, H2 2019
Gastric Cancer - Pipeline by CStone Pharmaceuticals Co Ltd, H2 2019
Gastric Cancer - Pipeline by Cumberland Pharmaceuticals Inc, H2 2019
Gastric Cancer - Pipeline by Curegenix Inc, H2 2019
Gastric Cancer - Pipeline by CureLab Oncology Inc, H2 2019
Gastric Cancer - Pipeline by CureMeta LLC, H2 2019
Gastric Cancer - Pipeline by Cynvec LLC, H2 2019
Gastric Cancer - Pipeline by Cytocom Inc, H2 2019
Gastric Cancer - Pipeline by Cytodyn Inc, H2 2019
Gastric Cancer - Pipeline by CytoMed Therapeutics Pte Ltd, H2 2019
Gastric Cancer - Pipeline by CytomX Therapeutics Inc, H2 2019
Gastric Cancer - Pipeline by Daiichi Sankyo Co Ltd, H2 2019
Gastric Cancer - Pipeline by Delta-Fly Pharma Inc, H2 2019
Gastric Cancer - Pipeline by DiNonA Inc, H2 2019
Gastric Cancer - Pipeline by DM Bio Ltd, H2 2019
Gastric Cancer - Pipeline by Dr. Reddy's Laboratories Ltd, H2 2019
Gastric Cancer - Pipeline by DrugCendR Inc, H2 2019
Gastric Cancer - Pipeline by Eddingpharm Inc, H2 2019
Gastric Cancer - Pipeline by eFFECTOR Therapeutics Inc, H2 2019
Gastric Cancer - Pipeline by EirGenix Inc, H2 2019
Gastric Cancer - Pipeline by Eisai Co Ltd, H2 2019
Gastric Cancer - Pipeline by Eli Lilly and Co, H2 2019
Gastric Cancer - Pipeline by EOS Biosciences Inc, H2 2019
Gastric Cancer - Pipeline by Erytech Pharma SA, H2 2019
Gastric Cancer - Pipeline by Esperance Pharmaceuticals Inc, H2 2019
Gastric Cancer - Pipeline by Eutilex Co Ltd, H2 2019
Gastric Cancer - Pipeline by Exelixis Inc, H2 2019
Gastric Cancer - Pipeline by F. Hoffmann-La Roche Ltd, H2 2019
Gastric Cancer - Pipeline by F1 Oncology Inc, H2 2019
Gastric Cancer - Pipeline by Faron Pharmaceuticals Oy, H2 2019
Gastric Cancer - Pipeline by Fate Therapeutics Inc, H2 2019
Gastric Cancer - Pipeline by Five Prime Therapeutics Inc, H2 2019
Gastric Cancer - Pipeline by Frost Biologic Inc, H2 2019
Gastric Cancer - Pipeline by G+FLAS Life Sciences Inc, H2 2019
Gastric Cancer - Pipeline by GEMoaB Monoclonals GmbH, H2 2019
Gastric Cancer - Pipeline by Geneius Biotechnology Inc, H2 2019
Gastric Cancer - Pipeline by Genentech Inc, H2 2019
Gastric Cancer - Pipeline by GeneScience Pharmaceuticals Co Ltd, H2 2019
Gastric Cancer - Pipeline by Genmab A/S, H2 2019
Gastric Cancer - Pipeline by Gilead Sciences Inc, H2 2019
Gastric Cancer - Pipeline by GlaxoSmithKline Plc, H2 2019
Gastric Cancer - Pipeline by GLG Pharma SA, H2 2019
Gastric Cancer - Pipeline by GlycoNex Inc, H2 2019
Gastric Cancer - Pipeline by Glycotope GmbH, H2 2019
Gastric Cancer - Pipeline by Good T Cells Inc, H2 2019
Gastric Cancer - Pipeline by Gossamer Bio Inc, H2 2019
Gastric Cancer - Pipeline by Green Cross LabCell Corp, H2 2019
Gastric Cancer - Pipeline by Grid Therapeutics LLC, H2 2019
Gastric Cancer - Pipeline by Guangdong Zhongsheng Pharmaceutical Co Ltd, H2 2019
Gastric Cancer - Pipeline by Hangzhou DAC Biotech Co Ltd, H2 2019
Gastric Cancer - Pipeline by Hanmi Pharmaceuticals Co Ltd, H2 2019
Gastric Cancer - Pipeline by Harbin Gloria Pharmaceuticals Co Ltd, H2 2019
Gastric Cancer - Pipeline by Harbour BioMed, H2 2019
Gastric Cancer - Pipeline by Hengenix Biotech Inc, H2 2019
Gastric Cancer - Pipeline by HengRui YuanZheng Bio-Technology Co Ltd, H2 2019
Gastric Cancer - Pipeline by Hope Biosciences Inc, H2 2019
Gastric Cancer - Pipeline by Horizon Therapeutics PLC, H2 2019
Gastric Cancer - Pipeline by Hummingbird Bioscience Pte Ltd, H2 2019
Gastric Cancer - Pipeline by Hutchison MediPharma Ltd, H2 2019
Gastric Cancer - Pipeline by I-Mab Biopharma Co Ltd, H2 2019
Gastric Cancer - Pipeline by Ichnos Sciences Inc, H2 2019
Gastric Cancer - Pipeline by Igem Therapeutics Ltd, H2 2019
Gastric Cancer - Pipeline by Ildong Pharmaceutical Co Ltd, H2 2019
Gastric Cancer - Pipeline by Immunicum AB, H2 2019
Gastric Cancer - Pipeline by Immunocore Ltd, H2 2019
Gastric Cancer - Pipeline by Immunomedics Inc, H2 2019
Gastric Cancer - Pipeline by Immunomet Therapeutics Inc, H2 2019
Gastric Cancer - Pipeline by Immunomic Therapeutics Inc, H2 2019
Gastric Cancer - Pipeline by Imugene Ltd, H2 2019
Gastric Cancer - Pipeline by Incyte Corp, H2 2019
Gastric Cancer - Pipeline by Inhibrx Inc, H2 2019
Gastric Cancer - Pipeline by InnoCare Pharma Ltd, H2 2019
Gastric Cancer - Pipeline by Innovative Cellular Therapeutics Co Ltd, H2 2019
Gastric Cancer - Pipeline by Innovent Biologics Inc, H2 2019
Gastric Cancer - Pipeline by Inovio Pharmaceuticals Inc, H2 2019
Gastric Cancer - Pipeline by Intezyne Inc, H2 2019
Gastric Cancer - Pipeline by Intra-Immusg Pvt Ltd, H2 2019
Gastric Cancer - Pipeline by Ipsen SA, H2 2019
Gastric Cancer - Pipeline by Jeil Pharmaceutical Co Ltd, H2 2019
Gastric Cancer - Pipeline by JHL Biotech Inc, H2 2019
Gastric Cancer - Pipeline by Jiangsu Alphamab Biopharmaceuticals Co Ltd, H2 2019
Gastric Cancer - Pipeline by Jiangsu Atom Bioscience and Pharmaceutical Co Ltd, H2 2019
Gastric Cancer - Pipeline by Jiangsu Hengrui Medicine Co Ltd, H2 2019
Gastric Cancer - Pipeline by Jiangsu Kanion Pharmaceutical Co Ltd, H2 2019
Gastric Cancer - Pipeline by Jiuzhitang Co Ltd, H2 2019
Gastric Cancer - Pipeline by Johnson & Johnson, H2 2019
Gastric Cancer - Pipeline by Jounce Therapeutics Inc, H2 2019
Gastric Cancer - Pipeline by JW Pharmaceutical Corp, H2 2019
Gastric Cancer - Pipeline by Kazia Therapeutics Ltd, H2 2019
Gastric Cancer - Pipeline by KLUS Pharma Inc, H2 2019
Gastric Cancer - Pipeline by Komipharm International Co Ltd, H2 2019
Gastric Cancer - Pipeline by Konruns Pharmaceutical Co Ltd, H2 2019
Gastric Cancer - Pipeline by Kringle Pharma Inc, H2 2019
Gastric Cancer - Pipeline by Kymab Ltd, H2 2019
Gastric Cancer - Pipeline by Kyowa Kirin Co Ltd, H2 2019
Gastric Cancer - Pipeline by LATITUDE Pharmaceuticals Inc, H2 2019
Gastric Cancer - Pipeline by LegoChem Biosciences Inc, H2 2019
Gastric Cancer - Pipeline by Lepu Medical Technology (Beijing) Co Ltd, H2 2019
Gastric Cancer - Pipeline by Mabpharm Ltd, H2 2019
Gastric Cancer - Pipeline by MacroGenics Inc, H2 2019
Gastric Cancer - Pipeline by MaxiVAX SA, H2 2019
Gastric Cancer - Pipeline by MBQ Pharma Inc, H2 2019
Gastric Cancer - Pipeline by MedAbome Inc, H2 2019
Gastric Cancer - Pipeline by Meditope Biosciences Inc, H2 2019
Gastric Cancer - Pipeline by MedPacto Inc, H2 2019
Gastric Cancer - Pipeline by Merck & Co Inc, H2 2019
Gastric Cancer - Pipeline by Merck KGaA, H2 2019
Gastric Cancer - Pipeline by Merus NV, H2 2019
Gastric Cancer - Pipeline by Metagone Biotech Inc, H2 2019
Gastric Cancer - Pipeline by Metis Precision Medicine, H2 2019
Gastric Cancer - Pipeline by Millennium Pharmaceuticals Inc, H2 2019
Gastric Cancer - Pipeline by Mitsubishi Tanabe Pharma Corp, H2 2019
Gastric Cancer - Pipeline by Moderna Therapeutics Inc, H2 2019
Gastric Cancer - Pipeline by Molecular Partners AG, H2 2019
Gastric Cancer - Pipeline by Molecular Templates Inc, H2 2019
Gastric Cancer - Pipeline by Moleculin Biotech LLC, H2 2019
Gastric Cancer - Pipeline by Mustang Bio Inc, H2 2019
Gastric Cancer - Pipeline by Mycenax Biotech Inc, H2 2019
Gastric Cancer - Pipeline by Nanjing Legend Biotech Co Ltd, H2 2019
Gastric Cancer - Pipeline by Nanjing Sanhome Pharmaceutical Co Ltd, H2 2019
Gastric Cancer - Pipeline by Nanjing Tianyi Bioscience Co Ltd, H2 2019
Gastric Cancer - Pipeline by NanoCarrier Co Ltd, H2 2019
Gastric Cancer - Pipeline by NBE-Therapeutics AG, H2 2019
Gastric Cancer - Pipeline by NeuClone Pty Ltd, H2 2019
Gastric Cancer - Pipeline by NewBio Therapeutics Inc, H2 2019
Gastric Cancer - Pipeline by NGM Biopharmaceuticals Inc, H2 2019
Gastric Cancer - Pipeline by Nouscom AG, H2 2019
Gastric Cancer - Pipeline by Novartis AG, H2 2019
Gastric Cancer - Pipeline by Novonco Pharmaceuticals Inc, H2 2019
Gastric Cancer - Pipeline by OBI Pharma Inc, H2 2019
Gastric Cancer - Pipeline by Ona Therapeutics SL, H2 2019
Gastric Cancer - Pipeline by OncoImmune Inc, H2 2019
Gastric Cancer - Pipeline by Oncologie Inc, H2 2019
Gastric Cancer - Pipeline by Oncolys BioPharma Inc, H2 2019
Gastric Cancer - Pipeline by OncoMed Pharmaceuticals Inc, H2 2019
Gastric Cancer - Pipeline by OncoSynergy Inc, H2 2019
Gastric Cancer - Pipeline by OncoTherapy Science Inc, H2 2019
Gastric Cancer - Pipeline by Ono Pharmaceutical Co Ltd, H2 2019
Gastric Cancer - Pipeline by Onxeo SA, H2 2019
Gastric Cancer - Pipeline by Opsona Therapeutics Ltd, H2 2019
Gastric Cancer - Pipeline by Orano Med LLC, H2 2019
Gastric Cancer - Pipeline by Oxford BioTherapeutics Ltd, H2 2019
Gastric Cancer - Pipeline by Patrys Ltd, H2 2019
Gastric Cancer - Pipeline by Peptron Inc, H2 2019
Gastric Cancer - Pipeline by PersonGen Biomedicine Suzhou Co Ltd, H2 2019
Gastric Cancer - Pipeline by Pfizer Inc, H2 2019
Gastric Cancer - Pipeline by Phanes Therapeutics Inc, H2 2019
Gastric Cancer - Pipeline by Pharma Mar SA, H2 2019
Gastric Cancer - Pipeline by Pharmapraxis, H2 2019
Gastric Cancer - Pipeline by Phosplatin Therapeutics LLC, H2 2019
Gastric Cancer - Pipeline by Pieris Pharmaceuticals Inc, H2 2019
Gastric Cancer - Pipeline by Plus Therapeutics Inc, H2 2019
Gastric Cancer - Pipeline by PNB Vesper Life Science Pvt Ltd, H2 2019
Gastric Cancer - Pipeline by Polaris Pharmaceuticals Inc, H2 2019
Gastric Cancer - Pipeline by Prescient Therapeutics Ltd, H2 2019
Gastric Cancer - Pipeline by Prestige BioPharma Pte Ltd, H2 2019
Gastric Cancer - Pipeline by ProLynx LLC, H2 2019
Gastric Cancer - Pipeline by Puma Biotechnology Inc, H2 2019
Gastric Cancer - Pipeline by QED Therapeutics Inc, H2 2019
Gastric Cancer - Pipeline by Rakuten Medical Inc, H2 2019
Gastric Cancer - Pipeline by RAPT Therapeutics Inc, H2 2019
Gastric Cancer - Pipeline by RaQualia Pharma Inc, H2 2019
Gastric Cancer - Pipeline by Redx Pharma Plc, H2 2019
Gastric Cancer - Pipeline by RemeGen Ltd, H2 2019
Gastric Cancer - Pipeline by Rhizen Pharmaceuticals SA, H2 2019
Gastric Cancer - Pipeline by Richter Gedeon Nyrt, H2 2019
Gastric Cancer - Pipeline by RUS Pharmtech, H2 2019
Gastric Cancer - Pipeline by Samumed LLC, H2 2019
Gastric Cancer - Pipeline by Samyang Holdings Corp, H2 2019
Gastric Cancer - Pipeline by Sanofi, H2 2019
Gastric Cancer - Pipeline by Sapvax LLC, H2 2019
Gastric Cancer - Pipeline by Scancell Holdings Plc, H2 2019
Gastric Cancer - Pipeline by Seattle Genetics Inc, H2 2019
Gastric Cancer - Pipeline by SELLAS Life Sciences Group Inc, H2 2019
Gastric Cancer - Pipeline by Shandong Boan Biological Technology Co Ltd, H2 2019
Gastric Cancer - Pipeline by Shanghai Biomed-Union Biotechnology Co Ltd, H2 2019
Gastric Cancer - Pipeline by Shanghai GeneChem Co Ltd, H2 2019
Gastric Cancer - Pipeline by Shanghai Haihe Biopharma Co Ltd, H2 2019
Gastric Cancer - Pipeline by Shanghai Henlius Biotech Inc, H2 2019
Gastric Cancer - Pipeline by Shanghai Miracogen Inc, H2 2019
Gastric Cancer - Pipeline by Shanghai Pharmaceutical Co Ltd, H2 2019
Gastric Cancer - Pipeline by Shenzhen BinDeBio Ltd, H2 2019
Gastric Cancer - Pipeline by Shenzhen Fapon Biopharma Inc, H2 2019
Gastric Cancer - Pipeline by Shenzhen Hornetcorn Bio-technology Company Ltd, H2 2019
Gastric Cancer - Pipeline by Shionogi & Co Ltd, H2 2019
Gastric Cancer - Pipeline by Sichuan Kelun Pharmaceutical Co Ltd, H2 2019
Gastric Cancer - Pipeline by Siena Biotech SpA, H2 2019
Gastric Cancer - Pipeline by Sillajen Biotherapeutics, H2 2019
Gastric Cancer - Pipeline by Simcere Pharmaceutical Group, H2 2019
Gastric Cancer - Pipeline by Sino Biopharmaceutical Ltd, H2 2019
Gastric Cancer - Pipeline by Sinocelltech Ltd, H2 2019
Gastric Cancer - Pipeline by SN BioScience, H2 2019
Gastric Cancer - Pipeline by Sorrento Therapeutics Inc, H2 2019
Gastric Cancer - Pipeline by Sound Biologics, H2 2019
Gastric Cancer - Pipeline by Spring Bank Pharmaceuticals Inc, H2 2019
Gastric Cancer - Pipeline by Stemirna Therapeutics Inc, H2 2019
Gastric Cancer - Pipeline by StemMed Ltd, H2 2019
Gastric Cancer - Pipeline by Suntec Medical (Taiwan) Inc, H2 2019
Gastric Cancer - Pipeline by Supratek Pharma Inc, H2 2019
Gastric Cancer - Pipeline by Suzhou Zelgen Biopharmaceutical Co Ltd, H2 2019
Gastric Cancer - Pipeline by SynCore Biotechnology Co Ltd, H2 2019
Gastric Cancer - Pipeline by Synthon Holdings BV, H2 2019
Gastric Cancer - Pipeline by Taiho Pharmaceutical Co Ltd, H2 2019
Gastric Cancer - Pipeline by Takeda Pharmaceutical Co Ltd, H2 2019
Gastric Cancer - Pipeline by Takis Srl, H2 2019
Gastric Cancer - Pipeline by Tarveda Therapeutics Inc, H2 2019
Gastric Cancer - Pipeline by Tasly Pharmaceutical Group Co Ltd, H2 2019
Gastric Cancer - Pipeline by Tessa Therapeutics Pte Ltd, H2 2019
Gastric Cancer - Pipeline by Tonix Pharmaceuticals Inc, H2 2019
Gastric Cancer - Pipeline by Toray Industries Inc, H2 2019
Gastric Cancer - Pipeline by TOT Biopharm Co Ltd, H2 2019
Gastric Cancer - Pipeline by Treos Bio Ltd, H2 2019
Gastric Cancer - Pipeline by Trio Medicines Ltd, H2 2019
Gastric Cancer - Pipeline by Triumvira Immunologics Inc, H2 2019
Gastric Cancer - Pipeline by Turning Point Therapeutics Inc, H2 2019
Gastric Cancer - Pipeline by Turnstone Biologics Inc, H2 2019
Gastric Cancer - Pipeline by Tvardi Therapeutics Inc, H2 2019
Gastric Cancer - Pipeline by Tyg Oncology Ltd, H2 2019
Gastric Cancer - Pipeline by Ube Industries Ltd, H2 2019
Gastric Cancer - Pipeline by United BioPharma Inc, H2 2019
Gastric Cancer - Pipeline by Unum Therapeutics Inc, H2 2019
Gastric Cancer - Pipeline by Vaxon Biotech, H2 2019
Gastric Cancer - Pipeline by Venus Remedies Ltd, H2 2019
Gastric Cancer - Pipeline by Viracta Therapeutics Inc, H2 2019
Gastric Cancer - Pipeline by Viral Gene Inc, H2 2019
Gastric Cancer - Pipeline by Well Marker Bio Co Ltd, H2 2019
Gastric Cancer - Pipeline by Wuhan Binhui Biotechnology Co Ltd, H2 2019
Gastric Cancer - Pipeline by Wuhan YZY Biopharma Co Ltd, H2 2019
Gastric Cancer - Pipeline by Xcovery Holding Company LLC, H2 2019
Gastric Cancer - Pipeline by Xencor Inc, H2 2019
Gastric Cancer - Pipeline by Xiangxue Life Sciences, H2 2019
Gastric Cancer - Pipeline by XuanZhu Pharma Co Ltd, H2 2019
Gastric Cancer - Pipeline by Zai Lab Ltd, H2 2019
Gastric Cancer - Pipeline by Zhejiang Hisun Pharmaceutical Co Ltd, H2 2019
Gastric Cancer - Pipeline by Zhejiang Jianfeng Group Company Ltd, H2 2019
Gastric Cancer - Pipeline by Zhengda Tianqing Kangfang Shanghai Biomedical Technology Co Ltd, H2 2019
Gastric Cancer - Pipeline by Zymeworks Inc, H2 2019
Gastric Cancer - Dormant Projects, H2 2019
Gastric Cancer - Discontinued Products, H2 2019

List of Figures
Number of Products under Development for Gastric Cancer, H2 2019
Number of Products under Development by Companies, H2 2019
Number of Products under Development by Universities/Institutes, H2 2019
Number of Products by Top 10 Targets, H2 2019
Number of Products by Stage and Top 10 Targets, H2 2019
Number of Products by Top 10 Mechanism of Actions, H2 2019
Number of Products by Stage and Top 10 Mechanism of Actions, H2 2019
Number of Products by Top 10 Routes of Administration, H2 2019
Number of Products by Stage and Top 10 Routes of Administration, H2 2019
Number of Products by Top 10 Molecule Types, H2 2019
Number of Products by Stage and Top 10 Molecule Types, H2 2019
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • 3SBio Inc
  • AbbVie Inc
  • AbClon Inc
  • AbGenomics International Inc
  • Abion Inc
  • ABL Bio Inc
  • Abpro Corp
  • AD Pharmaceuticals Co Ltd
  • Adaptimmune Therapeutics Plc
  • ADC Therapeutics SA
  • Advenchen Laboratories LLC
  • Akeso Biopharma Inc
  • Alkermes Plc
  • Allist Shanghai Pharmaceutical Technology Co Ltd
  • Alteogen Inc
  • Altor Bioscience LLC
  • Ambrx Inc
  • amcure GmbH
  • Amgen Inc
  • Andes Biotechnologies
  • Anew Oncology Inc
  • Antikor Biopharma Ltd
  • Apollomics Inc
  • Apotex Inc
  • Arbele Ltd
  • Argonaut Therapeutics Ltd
  • Arromax Pharmatech Co Ltd
  • Asana BioSciences LLC
  • Ascelia Pharma AB
  • Ascenta Therapeutics Inc
  • AskAt Inc
  • Aslan Pharmaceuticals Ltd
  • Astellas Pharma Inc
  • AstraZeneca Plc
  • Atara Biotherapeutics Inc
  • Aurigene Discovery Technologies Ltd
  • Aurora BioPharma Inc
  • Basilea Pharmaceutica Ltd
  • Bayer AG
  • BeiGene Ltd
  • Beijing BGI-GBI Biotech Co Ltd
  • Beijing Hanmi Pharmaceutical Co Ltd
  • Beijing Mabworks Biotech Co Ltd
  • Beijing Syngentech Co Ltd
  • Bellicum Pharmaceuticals Inc
  • Benhealth Biopharmaceutical (Shenzhen) Co Ltd
  • Betta Pharmaceuticals Co Ltd
  • Bio-Thera Solutions Ltd
  • BioIntegrator Ltd
  • BioLineRx Ltd
  • BioMed Valley Discoveries Inc
  • Biosion Inc
  • Biotecnol Ltd
  • Boehringer Ingelheim International GmbH
  • Boston Biomedical Inc
  • Bristol-Myers Squibb Co
  • CalyGene Biotechnology Inc
  • Camel-IDS NV
  • Cancer Prevention Pharmaceuticals Inc
  • CARsgen Therapeutics Ltd
  • CAS-Lamvac Biotech Co Ltd
  • Catalent Inc
  • Celgene Corp
  • Celldex Therapeutics Inc
  • Cellestia Biotech AG
  • Cellid Co Ltd
  • Cellivery Therapeutics Inc
  • Cello Therapeutics Inc
  • Cellular Biomedicine Group Inc
  • Celon Pharma SA
  • Chia Tai Tianqing Pharmaceutical Group Co Ltd.
  • Chipscreen Biosciences Ltd
  • Chugai Pharmaceutical Co Ltd
  • CMG Pharmaceutical Co Ltd
  • Coherent Biopharma
  • Convalife
  • Cristal Therapeutics BV
  • CSPC Pharmaceutical Group Ltd
  • CStone Pharmaceuticals Co Ltd
  • Cumberland Pharmaceuticals Inc
  • Curegenix Inc
  • CureLab Oncology Inc
  • CureMeta LLC
  • Cynvec LLC
  • Cytocom Inc
  • Cytodyn Inc
  • CytoMed Therapeutics Pte Ltd
  • CytomX Therapeutics Inc
  • Daiichi Sankyo Co Ltd
  • Delta-Fly Pharma Inc
  • DiNonA Inc
  • DM Bio Ltd
  • Dr. Reddy's Laboratories Ltd
  • DrugCendR Inc
  • Eddingpharm Inc
  • eFFECTOR Therapeutics Inc
  • EirGenix Inc
  • Eisai Co Ltd
  • Eli Lilly and Co
  • EOS Biosciences Inc
  • Erytech Pharma SA
  • Esperance Pharmaceuticals Inc
  • Eutilex Co Ltd
  • Exelixis Inc
  • F. Hoffmann-La Roche Ltd
  • F1 Oncology Inc
  • Faron Pharmaceuticals Oy
  • Fate Therapeutics Inc
  • Five Prime Therapeutics Inc
  • Frost Biologic Inc
  • G+FLAS Life Sciences Inc
  • GEMoaB Monoclonals GmbH
  • Geneius Biotechnology Inc
  • Genentech Inc
  • GeneScience Pharmaceuticals Co Ltd
  • Genmab A/S
  • Gilead Sciences Inc
  • GlaxoSmithKline Plc
  • GLG Pharma SA
  • GlycoNex Inc
  • Glycotope GmbH
  • Good T Cells Inc
  • Gossamer Bio Inc
  • Green Cross LabCell Corp
  • Grid Therapeutics LLC
  • Guangdong Zhongsheng Pharmaceutical Co Ltd
  • Hangzhou DAC Biotech Co Ltd
  • Hanmi Pharmaceuticals Co Ltd
  • Harbin Gloria Pharmaceuticals Co Ltd
  • Harbour BioMed
  • Hengenix Biotech Inc
  • HengRui YuanZheng Bio-Technology Co Ltd
  • Hope Biosciences Inc
  • Horizon Therapeutics PLC
  • Hummingbird Bioscience Pte Ltd
  • Hutchison MediPharma Ltd
  • I-Mab Biopharma Co Ltd
  • Ichnos Sciences Inc
  • Igem Therapeutics Ltd
  • Ildong Pharmaceutical Co Ltd
  • Immunicum AB
  • Immunocore Ltd
  • Immunomedics Inc
  • Immunomet Therapeutics Inc
  • Immunomic Therapeutics Inc
  • Imugene Ltd
  • Incyte Corp
  • Inhibrx Inc
  • InnoCare Pharma Ltd
  • Innovative Cellular Therapeutics Co Ltd
  • Innovent Biologics Inc
  • Inovio Pharmaceuticals Inc
  • Intezyne Inc
  • Intra-Immusg Pvt Ltd
  • Ipsen SA
  • Jeil Pharmaceutical Co Ltd
  • JHL Biotech Inc
  • Jiangsu Alphamab Biopharmaceuticals Co Ltd
  • Jiangsu Atom Bioscience and Pharmaceutical Co Ltd
  • Jiangsu Hengrui Medicine Co Ltd
  • Jiangsu Kanion Pharmaceutical Co Ltd
  • Jiuzhitang Co Ltd
  • Johnson & Johnson
  • Jounce Therapeutics Inc
  • JW Pharmaceutical Corp
  • Kazia Therapeutics Ltd
  • KLUS Pharma Inc
  • Komipharm International Co Ltd
  • Konruns Pharmaceutical Co Ltd
  • Kringle Pharma Inc
  • Kymab Ltd
  • Kyowa Kirin Co Ltd
  • LATITUDE Pharmaceuticals Inc
  • LegoChem Biosciences Inc
  • Lepu Medical Technology (Beijing) Co Ltd
  • Mabpharm Ltd
  • MacroGenics Inc
  • MaxiVAX SA
  • MBQ Pharma Inc
  • MedAbome Inc
  • Meditope Biosciences Inc
  • MedPacto Inc
  • Merck & Co Inc
  • Merck KGaA
  • Merus NV
  • Metagone Biotech Inc
  • Metis Precision Medicine
  • Millennium Pharmaceuticals Inc
  • Mitsubishi Tanabe Pharma Corp
  • Moderna Therapeutics Inc
  • Molecular Partners AG
  • Molecular Templates Inc
  • Moleculin Biotech LLC
  • Mustang Bio Inc
  • Mycenax Biotech Inc
  • Nanjing Legend Biotech Co Ltd
  • Nanjing Sanhome Pharmaceutical Co Ltd
  • Nanjing Tianyi Bioscience Co Ltd
  • NanoCarrier Co Ltd
  • NBE-Therapeutics AG
  • NeuClone Pty Ltd
  • NewBio Therapeutics Inc
  • NGM Biopharmaceuticals Inc
  • Nouscom AG
  • Novartis AG
  • Novonco Pharmaceuticals Inc
  • OBI Pharma Inc
  • Ona Therapeutics SL
  • OncoImmune Inc
  • Oncologie Inc
  • Oncolys BioPharma Inc
  • OncoMed Pharmaceuticals Inc
  • OncoSynergy Inc
  • OncoTherapy Science Inc
  • Ono Pharmaceutical Co Ltd
  • Onxeo SA
  • Opsona Therapeutics Ltd
  • Orano Med LLC
  • Oxford BioTherapeutics Ltd
  • Patrys Ltd
  • Peptron Inc
  • PersonGen Biomedicine Suzhou Co Ltd
  • Pfizer Inc
  • Phanes Therapeutics Inc
  • Pharma Mar SA
  • Pharmapraxis
  • Phosplatin Therapeutics LLC
  • Pieris Pharmaceuticals Inc
  • Plus Therapeutics Inc
  • PNB Vesper Life Science Pvt Ltd
  • Polaris Pharmaceuticals Inc
  • Prescient Therapeutics Ltd
  • Prestige BioPharma Pte Ltd
  • ProLynx LLC
  • Puma Biotechnology Inc
  • QED Therapeutics Inc
  • Rakuten Medical Inc
  • RAPT Therapeutics Inc
  • RaQualia Pharma Inc
  • Redx Pharma Plc
  • RemeGen Ltd
  • Rhizen Pharmaceuticals SA
  • Richter Gedeon Nyrt
  • RUS Pharmtech
  • Samumed LLC
  • Samyang Holdings Corp
  • Sanofi
  • Sapvax LLC
  • Scancell Holdings Plc
  • Seattle Genetics Inc
  • SELLAS Life Sciences Group Inc
Note: Product cover images may vary from those shown
Adroll
adroll